Literature DB >> 2901603

Spaced administration of antibiotic combinations to eliminate pseudomonas from sputum in cystic fibrosis.

J P Guggenbichler, F Allerberger, M P Dierich, R Schmitzberger, E Semenitz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2901603     DOI: 10.1016/s0140-6736(88)90226-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Use of pharmacodynamic parameters to predict efficacy of combination therapy by using fractional inhibitory concentration kinetics.

Authors:  J G den Hollander; J W Mouton; H A Verbrugh
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

2.  Bacterial reservoirs in cystic fibrosis.

Authors:  C J Taylor; J McGaw; R Howden; B I Duerden; P S Baxter
Journal:  Arch Dis Child       Date:  1990-02       Impact factor: 3.791

3.  Synergism between tobramycin and ceftazidime against a resistant Pseudomonas aeruginosa strain, tested in an in vitro pharmacokinetic model.

Authors:  J G den Hollander; A M Horrevorts; M L van Goor; H A Verbrugh; J W Mouton
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

Review 4.  The physiology and genetics of bacterial responses to antibiotic combinations.

Authors:  Roderich Roemhild; Tobias Bollenbach; Dan I Andersson
Journal:  Nat Rev Microbiol       Date:  2022-03-03       Impact factor: 78.297

5.  Improved efficacy with nonsimultaneous administration of first doses of gentamicin and ceftazidime in vitro.

Authors:  M L Barclay; E J Begg; S T Chambers; D R Boswell
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

6.  Cellular hysteresis as a principle to maximize the efficacy of antibiotic therapy.

Authors:  Roderich Roemhild; Chaitanya S Gokhale; Philipp Dirksen; Christopher Blake; Philip Rosenstiel; Arne Traulsen; Dan I Andersson; Hinrich Schulenburg
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-12       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.